The progression of the healthcare industry toward efficient and cost-effective healthcare solutions has had a huge impact on the medical devices, life sciences, and pharmaceutical sectors. It has resulted in new healthcare reforms in existing institutions and facilities in countries such as the US, the UK, India, and China. As the numbers of older people increase in both the developed and developing world, the demand for healthcare services and the need for health insurance companies to provide affordable health insurance will increase significantly.
Developed countries are shifting their focus towards preventive medicine and long-term care as part of their cost-containment strategies. The evolving stringent regulatory landscape further increases the complexity of healthcare management practices. Developing countries such as China, India, and Brazil are focusing on increasing access to healthcare and improving healthcare infrastructure.
The ultimate goal of every state is to provide high-quality healthcare services at an affordable cost. To this end, vendors need to deliver cost-effective products without compromising quality. The need for healthcare innovation has led to an increase in R&D investments and strategic alliances among healthcare entities and research institutes.
Technavio’s healthcare domain provides intelligence and insight to stakeholders in this sector to make informed decisions on expansion, diversification, and other strategic and marketing initiatives. Our portfolio of reports includes oncology, cardiovascular and metabolic disorders, central nervous system, men’s health, women’s health, and genitourinary ife sciences, vaccines, infectious and rare diseases, medical imaging, cardiovascular devices, patient monitoring, urology devices, orthopedic and general medical devices, life science research tools, in-vitro diagnostics.